ERBB2 and differentiated thyroid carcinoma: EMMPRIN and HER-2 could jointly control MMP activity and collaboratively promote the LNM of papillary thyroid carcinoma, therefore being jointly involved in the occurrence, development and metastasis of papillary thyroid carcinoma.